Bendazac Molecular: Origine, History, Uses, Interactions, and Theoretical Modelisation Study

Bendazac (4-benzyl-1,3-oxazolidine-2-one-5-acetic acid) is a non-steroidal anti-inflammatory compound known for its capacity to inhibit protein denaturation and stabilize lens crystallins (Stavrovskaya, I. G., & Baranova, M. I. (2011)) Research over the past decade has renewed interest in Bendazac and its lysine salt (bendazac-lysine) due to their protective effects against oxidative stress and lens protein aggregation, mechanisms strongly associated with cataract formation (Stefek, M. (2011)). Experimental studies demonstrate that Bendazac prevents heat- and UV-induced unfolding of α-crystallin and reduces insoluble protein aggregation in lens epithelial cells (Kumar, P., et al. (2014)). Additionally, Bendazac exhibits antioxidant action by attenuating reactive oxygen species and preserving glutathione homeostasis, further contributing to lens protection (Sun, M., et al. (2017)). Pharmacokinetic evaluations confirm that Bendazac is orally absorbed and primarily biotransformed into 5-hydroxy-bendazac, which retains biological activity . Although clinical trials continue to show only moderate anti-cataract efficacy, Bendazac remains an important model molecule for studying protein-stabilizing agents and lens-protective therapeutics (Dawczynski, J., & Königsdörffer, E. (2015)). More recent analytical and molecular studies highlight its potential value but emphasize the need for advanced, well-controlled human trials to clarify clinical benefit and safety